INTERNATIONAL PATENT: MISSION THERAPEUTICS LIMITED FILES APPLICATION FOR "N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS"

GENEVA, Dec. 29 -- MISSION THERAPEUTICS LIMITED (McClintock BuildingGranta ParkCambridge Cambridgeshire CB21 6GP) filed a patent application (PCT/GB2025/051369) for " N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS" on Jun 19, 2025. With publication no. WO/2025/262433, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KEMP, Mark Ian (c/o Mission Therapeutics LimitedMcClintock BuildingGranta ParkCambridge Cambridgeshire CB21 6GP), ALANINE, Thomas (c/o Mission Therapeutics LimitedMcClintock BuildingGranta ParkCambridge...